Virus-Like-Vaccines against HIV
Protection against chronic infections has necessitated the development of ever-more potent vaccination tools.HIV seems to be the most challenging foe, with a remarkable, poorly immunogenic and fragile surface glycoprotein and the ability to overpower the cell immune system.Virus-like-particle (VLP) vaccines have emerged as potent inducers of antibo